Artelo Biosciences Stock Alpha and Beta Analysis
| ARTL Stock | USD 1.49 0.09 5.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Artelo Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Artelo Biosciences over a specified time horizon. Remember, high Artelo Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Artelo Biosciences' market risk premium analysis include:
Beta 0.0762 | Alpha (1.61) | Risk 8.1 | Sharpe Ratio (0.22) | Expected Return (1.79) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Artelo Biosciences Backtesting, Artelo Biosciences Valuation, Artelo Biosciences Correlation, Artelo Biosciences Hype Analysis, Artelo Biosciences Volatility, Artelo Biosciences History and analyze Artelo Biosciences Performance. Artelo Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Artelo Biosciences market risk premium is the additional return an investor will receive from holding Artelo Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Artelo Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Artelo Biosciences' performance over market.| α | -1.61 | β | 0.08 |
Artelo Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Artelo Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Artelo Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Artelo Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Artelo Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Artelo Biosciences shares will generate the highest return on investment. By understating and applying Artelo Biosciences stock market price indicators, traders can identify Artelo Biosciences position entry and exit signals to maximize returns.
Artelo Biosciences Return and Market Media
The median price of Artelo Biosciences for the period between Sun, Sep 28, 2025 and Sat, Dec 27, 2025 is 2.06 with a coefficient of variation of 46.31. The daily time series for the period is distributed with a sample standard deviation of 1.36, arithmetic mean of 2.93, and mean deviation of 1.21. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Artelo Biosciences Announces Expanded Clinical Data to be Presented on both ART26.12 and ART27.13 at the 8th Annual Cannabinoid Endocannabinoid Drug Development... | 10/15/2025 |
2 | Acquisition by Emanuele Robert Martin of 10000 shares of Artelo Biosciences subject to Rule 16b-3 | 10/16/2025 |
3 | What momentum shifts mean for Artelo Biosciences Inc. - Quarterly Portfolio Report Smart Money Movement Alerts - newser.com | 10/30/2025 |
4 | Why Artelo Biosciences Inc. stock appeals to analysts - 2025 Breakouts Breakdowns Consistent Return Strategy Ideas - fcp.pa.gov.br | 11/06/2025 |
5 | Will Artelo Biosciences Inc. outperform the market - Trade Risk Assessment Free High Return Stock Watch Alerts - newser.com | 11/11/2025 |
6 | Acquisition by Favorito Tamara A of 1083 shares of Artelo Biosciences at 1.55 subject to Rule 16b-3 | 11/14/2025 |
7 | Maxim Downgrades Artelo Biosciences to Hold From Buy - MarketScreener | 11/19/2025 |
8 | 12 Health Care Stocks Moving In Mondays After-Market Session - Benzinga | 12/01/2025 |
9 | Artelo Biosciences Announces Publication of New Peer-Reviewed Study Demonstrating Intraperitoneal Administration of a Novel Fatty Acid Binding Protein 5 Inhibit... | 12/03/2025 |
10 | Is Artelo Biosciences Inc. stock a buy in volatile markets - 2025 Investor Takeaways Comprehensive Market Scan Reports - DonanmHaber | 12/19/2025 |
11 | Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Cand... | 12/23/2025 |
About Artelo Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Artelo or other stocks. Alpha measures the amount that position in Artelo Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2024 | 2025 (projected) | Net Debt To EBITDA | 0.68 | 0.22 | 0.21 | Intangibles To Total Assets | 0.0998 | 0.43 | 0.3 |
Artelo Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Artelo Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Artelo Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Artelo Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Artelo Biosciences. Please utilize our Beneish M Score to check the likelihood of Artelo Biosciences' management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Artelo Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Artelo Biosciences Backtesting, Artelo Biosciences Valuation, Artelo Biosciences Correlation, Artelo Biosciences Hype Analysis, Artelo Biosciences Volatility, Artelo Biosciences History and analyze Artelo Biosciences Performance. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Artelo Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.